Verve Therapeutics
VERV
A$17.06
Share price
0.00%
Change (1 day)
56.97%
Change (1 year)
Verve Therapeutics (VERV) - Cash on Hand
Cash on Hand as of March 2025 : A$0.76 Billion
According to Verve Therapeutics's latest financial reports the company has A$0.76 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Verve Therapeutics - Cash on Hand chart (from 2020 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | A$0.84 B | -7.96% |
| 2023-12-31 | A$0.91 B | 12.33% |
| 2022-12-31 | A$0.81 B | 63.98% |
| 2021-12-31 | A$0.49 B | 430.14% |
| 2020-12-31 | A$93.78 M | 249.59% |
| 2019-12-31 | A$26.82 M |